ARCHIVES

Study Of Tamoxifen And Raloxifene Enrolls 6,000 In First Year; 5 Percent Are Minorities

This article is from The Cancer Letter archive.

Vol. 23 No. 7 | July 28, 2000

Download PDF Visit The Full Archive

Related Articles

Advisors Ok New RFP For Natural Product Large-Scale Production

March 6, 1992

Prostate Cancer Patient Groups Consider formation Of Coalition Using the “NBCC Model”

August 16, 1996

IOM: No Negligence In FIAU Clinical Trial That Killed Five

March 31, 1995

Almost Half of Faculty on IRBs Have Industry Ties, Study Finds

September 26, 2003

ACCC Unit Reaches Consensus On Outline of HOP; Each Member Would Relate To Center Or Cooperative Group

September 11, 1981

Chabner, FDA’s Temple continue disagreement Over Drug Approval

February 10, 1989